has acquired
Follow-on Public Offering
of Common Stock
$3,400,000
$240,000,000
Rule 144A Offering of
1.25% Convertible Senior Notes
Due 2023
has been acquired by
has been acquired by
has merged with
has acquired
Follow-on Public Offering
of Common Stock
$63,250,008
Secondary Public Offering
$298,380,000
has merged with
Receivables Securitization
Financing
$250,000,000
Series A Financing
Up to $6 Million
has received a
growth equity investment from
Eli Lilly and Company
has acquired
AurKa Pharma, Inc.
$110,000,000 plus
up to $465,000,000
in regulatory and sales
milestones
has acquired
a majority interest in
Follow-on Public Offering
of Common Stock
$19,968,000
has acquired the assets of
has acquired
has been acquired by
Series A Financing
$4,600,000
has acquired
Series A Financing
$4,500,000
has acquired
has acquired
certain assets from
has merged with
TowneBank
has been acquired by
Press Ganey Associates
has acquired
License and
Development Agreement
has acquired
has been acquired by
has been acquired by
Shred-it USA, a subsidiary of
Stericycle (SRCL)
$19,500,000
Regulation A+ Offering
has acquired
has merged with
